Deep Learning Analysis of Upright-Supine High-Efficiency SPECT Myocardial Perfusion Imaging for Prediction of Obstructive Coronary Artery Disease: A Multicenter Study.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published Date:

Abstract

Combined analysis of SPECT myocardial perfusion imaging (MPI) performed with a solid-state camera on patients in 2 positions (semiupright, supine) is routinely used to mitigate attenuation artifacts. We evaluated the prediction of obstructive disease from combined analysis of semiupright and supine stress MPI by deep learning (DL) as compared with standard combined total perfusion deficit (TPD). 1,160 patients without known coronary artery disease (64% male) were studied. Patients underwent stress Tc-sestamibi MPI with new-generation solid-state SPECT scanners in 4 different centers. All patients had on-site clinical reads and invasive coronary angiography correlations within 6 mo of MPI. Obstructive disease was defined as at least 70% narrowing of the 3 major coronary arteries and at least 50% for the left main coronary artery. Images were quantified at Cedars-Sinai. The left ventricular myocardium was segmented using standard clinical nuclear cardiology software. The contour placement was verified by an experienced technologist. Combined stress TPD was computed using sex- and camera-specific normal limits. DL was trained using polar distributions of normalized radiotracer counts, hypoperfusion defects, and hypoperfusion severities and was evaluated for prediction of obstructive disease in a novel leave-one-center-out cross-validation procedure equivalent to external validation. During the validation procedure, 4 DL models were trained using data from 3 centers and then evaluated on the 1 center left aside. Predictions for each center were merged to have an overall estimation of the multicenter performance. 718 (62%) patients and 1,272 of 3,480 (37%) arteries had obstructive disease. The area under the receiver operating characteristics curve for prediction of disease on a per-patient and per-vessel basis by DL was higher than for combined TPD (per-patient, 0.81 vs. 0.78; per-vessel, 0.77 vs. 0.73; < 0.001). With the DL cutoff set to exhibit the same specificity as the standard cutoff for combined TPD, per-patient sensitivity improved from 61.8% (TPD) to 65.6% (DL) ( < 0.05), and per-vessel sensitivity improved from 54.6% (TPD) to 59.1% (DL) ( < 0.01). With the threshold matched to the specificity of a normal clinical read (56.3%), DL had a sensitivity of 84.8%, versus 82.6% for an on-site clinical read ( = 0.3). DL improves automatic interpretation of MPI as compared with current quantitative methods.

Authors

  • Julian Betancur
    Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California.
  • Lien-Hsin Hu
    Division of Nuclear Medicine, Department of Imaging, and Departments of Medicine and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California.
  • Frederic Commandeur
  • Tali Sharir
    Department of Nuclear Cardiology, Assuta Medical Centers, Tel Aviv, Israel.
  • Andrew J Einstein
    Division of Cardiology, Department of Medicine, Columbia University Medical Center and New York-Presbyterian Hospital, New York, New York; Department of Radiology, Columbia University Medical Center and New York-Presbyterian Hospital, New York, New York.
  • Mathews B Fish
    Oregon Heart and Vascular Institute, Sacred Heart Medical Center, Springfield, Oregon.
  • Terrence D Ruddy
    Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Canada.
  • Philipp A Kaufmann
    Cardiac Imaging, Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland; and.
  • Albert J Sinusas
    Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
  • Edward J Miller
    Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States.
  • Timothy M Bateman
    Cardiovascular Imaging Technologies LLC, Kansas City, Missouri.
  • Sharmila Dorbala
    Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, Massachusetts.
  • Marcelo Di Carli
    Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, Massachusetts.
  • Guido Germano
    Departments of Imaging and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Yuka Otaki
    Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California.
  • Joanna X Liang
    Division of Nuclear Medicine, Department of Imaging, and Departments of Medicine and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California.
  • Balaji K Tamarappoo
  • Damini Dey
    Departments of Imaging and Medicine, and Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Taper A238, Los Angeles, CA, 90048, USA.
  • Daniel S Berman
    Departments of Imaging and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Piotr J Slomka
    Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California Piotr.Slomka@cshs.org.